AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Psychedelics and Drug Policy Reform
The end of 2023 is when FDA approval for the prescription use of MDMA for PTSD will be approved. In Canada now, they're letting people have compassionate access to psilocybin for life threatening illness. We already are starting to see the decriminalization in certain areas of plant psychedelics. Then what we're going to need is a decade of psychedelic clinics that are going to roll out across America and other countries.